Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.
about
Celiac disease: prevalence, diagnosis, pathogenesis and treatmentCurrent and emerging therapy for celiac diseasePrevention measures and exploratory pharmacological treatments of celiac disease.Modulatory Effect of Gliadin Peptide 10-mer on Epithelial Intestinal CACO-2 Cell Inflammatory ResponseModeling of celiac disease immune response and the therapeutic effect of potential drugsInvestigation the Possibility of Using Peptides with a Helical Repeating Pattern of Hydro-Phobic and Hydrophilic Residues to Inhibit IL-10.Resolving multiple protein-peptide binding events: implication for HLA-DQ2 mediated antigen presentation in celiac disease.Investigational therapies for celiac disease.Coeliac disease--a diagnostic and therapeutic challenge.New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment.Celiac disease 2015 update: new therapies.Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.Physiopathology and Management of Gluten-Induced Celiac Disease.Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.Celiac disease: Alternatives to a gluten free diet.A practical total synthesis of the microbial alkaline proteinase inhibitor (MAPI).
P2860
Q22305490-711F2E02-BFF7-4F97-B620-1FD35B68FA79Q27014843-551CE654-E4F9-4B9D-8F72-1091510E7D98Q34623902-B7CF3B65-FADD-429F-8F80-AB433568DD29Q34792825-32403BEB-33D5-4BE6-941B-DBA8422F89C1Q34798574-0AF1F9C2-4E8B-4BA6-87CD-CE16961FFAC5Q35995841-C373D74E-90F6-4A76-8952-50A7BA32B7A7Q36055610-EF12512A-FE7F-4D3A-99F0-5AFFF46AA4DCQ37638684-CDC3BA70-6D32-450B-B7F4-A48DA5C2EC11Q37767725-2F6B5EB9-2971-4C47-821F-4C2E2C91F5E1Q37905046-09D6EC0C-6BE9-434E-B676-85B0911CC012Q38416745-04D222DF-77FC-4DD7-8D54-D6EFBD43E7A5Q39017211-E56111D9-606F-4E89-9D74-AEAB3701E354Q39111493-CBD7A68F-5682-40F4-9343-BE29CE62DCC9Q39162858-FD92A178-C58F-4F08-92D5-F44501F5016AQ42730481-3089122D-C8BF-4567-95F6-DBB632F3A93AQ43264722-F4901F3A-18B8-471B-8C09-29790B9F8877
P2860
Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Structure-based design of alph ...... LA-DQ2 and transglutaminase 2.
@en
Structure-based design of alph ...... LA-DQ2 and transglutaminase 2.
@nl
type
label
Structure-based design of alph ...... LA-DQ2 and transglutaminase 2.
@en
Structure-based design of alph ...... LA-DQ2 and transglutaminase 2.
@nl
prefLabel
Structure-based design of alph ...... LA-DQ2 and transglutaminase 2.
@en
Structure-based design of alph ...... LA-DQ2 and transglutaminase 2.
@nl
P2860
P1476
Structure-based design of alph ...... HLA-DQ2 and transglutaminase 2
@en
P2093
Chaitan Khosla
Matthew Siegel
P2860
P304
P356
10.1016/J.BMC.2007.06.020
P407
P50
P577
2007-06-13T00:00:00Z